nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—AKR1C1—polycystic ovary syndrome	0.695	1	CbGaD
Acetylsalicylic acid—PTGS2—ovarian follicle—polycystic ovary syndrome	0.00353	0.0362	CbGeAlD
Acetylsalicylic acid—TP53—embryo—polycystic ovary syndrome	0.00248	0.0254	CbGeAlD
Acetylsalicylic acid—NFKBIA—embryo—polycystic ovary syndrome	0.00244	0.025	CbGeAlD
Acetylsalicylic acid—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.00243	0.111	CcSEcCtD
Acetylsalicylic acid—Mefenamic acid—AKR1C2—polycystic ovary syndrome	0.0024	0.368	CrCbGaD
Acetylsalicylic acid—HSPA5—embryo—polycystic ovary syndrome	0.00239	0.0245	CbGeAlD
Acetylsalicylic acid—Acidosis—Metformin—polycystic ovary syndrome	0.00231	0.105	CcSEcCtD
Acetylsalicylic acid—CYP2C19—urine—polycystic ovary syndrome	0.00218	0.0224	CbGeAlD
Acetylsalicylic acid—RPS6KA3—embryo—polycystic ovary syndrome	0.00203	0.0209	CbGeAlD
Acetylsalicylic acid—NFKBIA—adrenal cortex—polycystic ovary syndrome	0.002	0.0205	CbGeAlD
Acetylsalicylic acid—HSPA5—adrenal cortex—polycystic ovary syndrome	0.00196	0.0201	CbGeAlD
Acetylsalicylic acid—Heartburn—Metformin—polycystic ovary syndrome	0.00186	0.0844	CcSEcCtD
Acetylsalicylic acid—TP53—endometrium—polycystic ovary syndrome	0.00181	0.0186	CbGeAlD
Acetylsalicylic acid—NFKBIA—endometrium—polycystic ovary syndrome	0.00178	0.0183	CbGeAlD
Acetylsalicylic acid—HSPA5—endometrium—polycystic ovary syndrome	0.00175	0.0179	CbGeAlD
Acetylsalicylic acid—CYP2C9—urine—polycystic ovary syndrome	0.00169	0.0174	CbGeAlD
Acetylsalicylic acid—TP53—uterus—polycystic ovary syndrome	0.00167	0.0171	CbGeAlD
Acetylsalicylic acid—RPS6KA3—adrenal cortex—polycystic ovary syndrome	0.00167	0.0171	CbGeAlD
Acetylsalicylic acid—NFKBIA—uterus—polycystic ovary syndrome	0.00164	0.0169	CbGeAlD
Acetylsalicylic acid—TP53—pituitary gland—polycystic ovary syndrome	0.00164	0.0168	CbGeAlD
Acetylsalicylic acid—TP53—adipose tissue—polycystic ovary syndrome	0.00163	0.0168	CbGeAlD
Acetylsalicylic acid—NFKBIA—pituitary gland—polycystic ovary syndrome	0.00161	0.0166	CbGeAlD
Acetylsalicylic acid—HSPA5—uterus—polycystic ovary syndrome	0.00161	0.0165	CbGeAlD
Acetylsalicylic acid—NFKBIA—adipose tissue—polycystic ovary syndrome	0.00161	0.0165	CbGeAlD
Acetylsalicylic acid—HSPA5—pituitary gland—polycystic ovary syndrome	0.00158	0.0162	CbGeAlD
Acetylsalicylic acid—HSPA5—adipose tissue—polycystic ovary syndrome	0.00157	0.0162	CbGeAlD
Acetylsalicylic acid—IKBKB—embryo—polycystic ovary syndrome	0.0015	0.0154	CbGeAlD
Acetylsalicylic acid—RPS6KA3—endometrium—polycystic ovary syndrome	0.00149	0.0153	CbGeAlD
Acetylsalicylic acid—Contusion—Metformin—polycystic ovary syndrome	0.00147	0.0666	CcSEcCtD
Acetylsalicylic acid—TP53—adrenal gland—polycystic ovary syndrome	0.00147	0.015	CbGeAlD
Acetylsalicylic acid—Chest discomfort—Metformin—polycystic ovary syndrome	0.00145	0.0657	CcSEcCtD
Acetylsalicylic acid—NFKBIA—adrenal gland—polycystic ovary syndrome	0.00144	0.0148	CbGeAlD
Acetylsalicylic acid—HSPA5—adrenal gland—polycystic ovary syndrome	0.00141	0.0145	CbGeAlD
Acetylsalicylic acid—RPS6KA3—uterus—polycystic ovary syndrome	0.00137	0.0141	CbGeAlD
Acetylsalicylic acid—TP53—female gonad—polycystic ovary syndrome	0.00137	0.014	CbGeAlD
Acetylsalicylic acid—TP53—vagina—polycystic ovary syndrome	0.00136	0.0139	CbGeAlD
Acetylsalicylic acid—EDNRA—adrenal cortex—polycystic ovary syndrome	0.00135	0.0139	CbGeAlD
Acetylsalicylic acid—RPS6KA3—pituitary gland—polycystic ovary syndrome	0.00135	0.0138	CbGeAlD
Acetylsalicylic acid—NFKBIA—female gonad—polycystic ovary syndrome	0.00134	0.0138	CbGeAlD
Acetylsalicylic acid—RPS6KA3—adipose tissue—polycystic ovary syndrome	0.00134	0.0138	CbGeAlD
Acetylsalicylic acid—NFKBIA—vagina—polycystic ovary syndrome	0.00134	0.0137	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—AKR1C1—polycystic ovary syndrome	0.00132	0.202	CrCbGaD
Acetylsalicylic acid—HSPA5—female gonad—polycystic ovary syndrome	0.00132	0.0135	CbGeAlD
Acetylsalicylic acid—HSPA5—vagina—polycystic ovary syndrome	0.00131	0.0134	CbGeAlD
Acetylsalicylic acid—TP53—endocrine gland—polycystic ovary syndrome	0.00127	0.013	CbGeAlD
Acetylsalicylic acid—NFKBIA—endocrine gland—polycystic ovary syndrome	0.00125	0.0128	CbGeAlD
Acetylsalicylic acid—HSPA5—endocrine gland—polycystic ovary syndrome	0.00122	0.0126	CbGeAlD
Acetylsalicylic acid—EDNRA—endometrium—polycystic ovary syndrome	0.00121	0.0124	CbGeAlD
Acetylsalicylic acid—RPS6KA3—adrenal gland—polycystic ovary syndrome	0.0012	0.0123	CbGeAlD
Acetylsalicylic acid—Lightheadedness—Metformin—polycystic ovary syndrome	0.00114	0.052	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—female gonad—polycystic ovary syndrome	0.00112	0.0115	CbGeAlD
Acetylsalicylic acid—RPS6KA3—vagina—polycystic ovary syndrome	0.00111	0.0114	CbGeAlD
Acetylsalicylic acid—EDNRA—uterus—polycystic ovary syndrome	0.00111	0.0114	CbGeAlD
Acetylsalicylic acid—IKBKB—endometrium—polycystic ovary syndrome	0.0011	0.0113	CbGeAlD
Acetylsalicylic acid—EDNRA—pituitary gland—polycystic ovary syndrome	0.00109	0.0112	CbGeAlD
Acetylsalicylic acid—EDNRA—adipose tissue—polycystic ovary syndrome	0.00109	0.0112	CbGeAlD
Acetylsalicylic acid—Salicylic acid—AKR1C1—polycystic ovary syndrome	0.00106	0.162	CrCbGaD
Acetylsalicylic acid—RPS6KA3—endocrine gland—polycystic ovary syndrome	0.00104	0.0107	CbGeAlD
Acetylsalicylic acid—IKBKB—uterus—polycystic ovary syndrome	0.00101	0.0104	CbGeAlD
Acetylsalicylic acid—IKBKB—pituitary gland—polycystic ovary syndrome	0.000994	0.0102	CbGeAlD
Acetylsalicylic acid—IKBKB—adipose tissue—polycystic ovary syndrome	0.00099	0.0102	CbGeAlD
Acetylsalicylic acid—Meclofenamic acid—AKR1C3—polycystic ovary syndrome	0.000984	0.151	CrCbGaD
Acetylsalicylic acid—EDNRA—adrenal gland—polycystic ovary syndrome	0.000978	0.01	CbGeAlD
Acetylsalicylic acid—Renal impairment—Metformin—polycystic ovary syndrome	0.000976	0.0443	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000951	0.0432	CcSEcCtD
Acetylsalicylic acid—EDNRA—female gonad—polycystic ovary syndrome	0.000912	0.00936	CbGeAlD
Acetylsalicylic acid—EDNRA—vagina—polycystic ovary syndrome	0.000906	0.0093	CbGeAlD
Acetylsalicylic acid—IKBKB—adrenal gland—polycystic ovary syndrome	0.000888	0.00911	CbGeAlD
Acetylsalicylic acid—IKBKB—female gonad—polycystic ovary syndrome	0.000828	0.00849	CbGeAlD
Acetylsalicylic acid—IKBKB—vagina—polycystic ovary syndrome	0.000823	0.00844	CbGeAlD
Acetylsalicylic acid—Influenza—Metformin—polycystic ovary syndrome	0.000802	0.0365	CcSEcCtD
Acetylsalicylic acid—IKBKB—endocrine gland—polycystic ovary syndrome	0.00077	0.0079	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—AKR1C3—polycystic ovary syndrome	0.000765	0.117	CrCbGaD
Acetylsalicylic acid—SLC22A7—endocrine gland—polycystic ovary syndrome	0.000747	0.00766	CbGeAlD
Acetylsalicylic acid—Drowsiness—Metformin—polycystic ovary syndrome	0.000715	0.0325	CcSEcCtD
Acetylsalicylic acid—Flushing—Metformin—polycystic ovary syndrome	0.000596	0.0271	CcSEcCtD
Acetylsalicylic acid—ALB—adrenal gland—polycystic ovary syndrome	0.000518	0.00532	CbGeAlD
Acetylsalicylic acid—Syncope—Metformin—polycystic ovary syndrome	0.000501	0.0228	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000491	0.0223	CcSEcCtD
Acetylsalicylic acid—Hypertension—Metformin—polycystic ovary syndrome	0.000483	0.0219	CcSEcCtD
Acetylsalicylic acid—PTGS2—embryo—polycystic ovary syndrome	0.000477	0.0049	CbGeAlD
Acetylsalicylic acid—Chest pain—Metformin—polycystic ovary syndrome	0.000476	0.0216	CcSEcCtD
Acetylsalicylic acid—CYP2C8—endometrium—polycystic ovary syndrome	0.000451	0.00462	CbGeAlD
Acetylsalicylic acid—Shock—Metformin—polycystic ovary syndrome	0.000449	0.0204	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000447	0.0203	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000441	0.02	CcSEcCtD
Acetylsalicylic acid—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000408	0.00418	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Metformin—polycystic ovary syndrome	0.000407	0.0185	CcSEcCtD
Acetylsalicylic acid—Somnolence—Metformin—polycystic ovary syndrome	0.000406	0.0184	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Metformin—polycystic ovary syndrome	0.000402	0.0182	CcSEcCtD
Acetylsalicylic acid—PTGS2—adrenal cortex—polycystic ovary syndrome	0.000391	0.00401	CbGeAlD
Acetylsalicylic acid—CYP2C19—vagina—polycystic ovary syndrome	0.000387	0.00397	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000376	0.0171	CcSEcCtD
Acetylsalicylic acid—PTGS1—endometrium—polycystic ovary syndrome	0.000365	0.00375	CbGeAlD
Acetylsalicylic acid—Urticaria—Metformin—polycystic ovary syndrome	0.000363	0.0165	CcSEcCtD
Acetylsalicylic acid—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000362	0.00371	CbGeAlD
Acetylsalicylic acid—PTGS2—endometrium—polycystic ovary syndrome	0.000349	0.00358	CbGeAlD
Acetylsalicylic acid—CYP2C8—vagina—polycystic ovary syndrome	0.000338	0.00346	CbGeAlD
Acetylsalicylic acid—PTGS1—uterus—polycystic ovary syndrome	0.000337	0.00345	CbGeAlD
Acetylsalicylic acid—PTGS1—pituitary gland—polycystic ovary syndrome	0.000331	0.00339	CbGeAlD
Acetylsalicylic acid—PTGS1—adipose tissue—polycystic ovary syndrome	0.000329	0.00338	CbGeAlD
Acetylsalicylic acid—Pruritus—Metformin—polycystic ovary syndrome	0.000323	0.0147	CcSEcCtD
Acetylsalicylic acid—PTGS2—uterus—polycystic ovary syndrome	0.000322	0.0033	CbGeAlD
Acetylsalicylic acid—PTGS2—pituitary gland—polycystic ovary syndrome	0.000316	0.00324	CbGeAlD
Acetylsalicylic acid—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000316	0.00324	CbGeAlD
Acetylsalicylic acid—PTGS2—adipose tissue—polycystic ovary syndrome	0.000315	0.00323	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Metformin—polycystic ovary syndrome	0.000312	0.0142	CcSEcCtD
Acetylsalicylic acid—Dizziness—Metformin—polycystic ovary syndrome	0.000302	0.0137	CcSEcCtD
Acetylsalicylic acid—PTGS1—adrenal gland—polycystic ovary syndrome	0.000295	0.00303	CbGeAlD
Acetylsalicylic acid—ABCB1—embryo—polycystic ovary syndrome	0.000295	0.00303	CbGeAlD
Acetylsalicylic acid—Vomiting—Metformin—polycystic ovary syndrome	0.00029	0.0132	CcSEcCtD
Acetylsalicylic acid—Rash—Metformin—polycystic ovary syndrome	0.000288	0.0131	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Metformin—polycystic ovary syndrome	0.000287	0.0131	CcSEcCtD
Acetylsalicylic acid—PTGS2—adrenal gland—polycystic ovary syndrome	0.000282	0.0029	CbGeAlD
Acetylsalicylic acid—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000281	0.00288	CbGeAlD
Acetylsalicylic acid—PTGS1—female gonad—polycystic ovary syndrome	0.000275	0.00283	CbGeAlD
Acetylsalicylic acid—PTGS1—vagina—polycystic ovary syndrome	0.000274	0.00281	CbGeAlD
Acetylsalicylic acid—Nausea—Metformin—polycystic ovary syndrome	0.000271	0.0123	CcSEcCtD
Acetylsalicylic acid—PTGS2—female gonad—polycystic ovary syndrome	0.000263	0.0027	CbGeAlD
Acetylsalicylic acid—PTGS2—vagina—polycystic ovary syndrome	0.000262	0.00268	CbGeAlD
Acetylsalicylic acid—PTGS1—endocrine gland—polycystic ovary syndrome	0.000256	0.00263	CbGeAlD
Acetylsalicylic acid—PTGS2—endocrine gland—polycystic ovary syndrome	0.000245	0.00251	CbGeAlD
Acetylsalicylic acid—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000242	0.00248	CbGeAlD
Acetylsalicylic acid—ABCB1—endometrium—polycystic ovary syndrome	0.000216	0.00222	CbGeAlD
Acetylsalicylic acid—ABCB1—uterus—polycystic ovary syndrome	0.000199	0.00204	CbGeAlD
Acetylsalicylic acid—ABCB1—pituitary gland—polycystic ovary syndrome	0.000196	0.00201	CbGeAlD
Acetylsalicylic acid—ABCB1—adipose tissue—polycystic ovary syndrome	0.000195	0.002	CbGeAlD
Acetylsalicylic acid—ABCB1—adrenal gland—polycystic ovary syndrome	0.000175	0.00179	CbGeAlD
Acetylsalicylic acid—ABCB1—female gonad—polycystic ovary syndrome	0.000163	0.00167	CbGeAlD
Acetylsalicylic acid—ABCB1—vagina—polycystic ovary syndrome	0.000162	0.00166	CbGeAlD
Acetylsalicylic acid—ABCB1—endocrine gland—polycystic ovary syndrome	0.000151	0.00155	CbGeAlD
Acetylsalicylic acid—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	7.98e-06	4.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	7.97e-06	4.44e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IGF1—polycystic ovary syndrome	7.96e-06	4.43e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT2—polycystic ovary syndrome	7.95e-06	4.43e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NAMPT—polycystic ovary syndrome	7.95e-06	4.43e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKR1C3—polycystic ovary syndrome	7.95e-06	4.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HMMR—polycystic ovary syndrome	7.92e-06	4.41e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.89e-06	4.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TNRC6B—polycystic ovary syndrome	7.82e-06	4.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	7.82e-06	4.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—STAR—polycystic ovary syndrome	7.79e-06	4.34e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	7.79e-06	4.34e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IRS1—polycystic ovary syndrome	7.77e-06	4.33e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IRS1—polycystic ovary syndrome	7.77e-06	4.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PGR—polycystic ovary syndrome	7.74e-06	4.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	7.7e-06	4.29e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL6—polycystic ovary syndrome	7.66e-06	4.26e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.64e-06	4.26e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	7.63e-06	4.25e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	7.6e-06	4.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	7.56e-06	4.21e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.56e-06	4.21e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—IL6—polycystic ovary syndrome	7.53e-06	4.19e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.51e-06	4.19e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—POMC—polycystic ovary syndrome	7.48e-06	4.17e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—POMC—polycystic ovary syndrome	7.48e-06	4.17e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.47e-06	4.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.46e-06	4.15e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—INS—polycystic ovary syndrome	7.44e-06	4.14e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—INS—polycystic ovary syndrome	7.44e-06	4.14e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	7.42e-06	4.13e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	7.41e-06	4.13e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	7.3e-06	4.06e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	7.28e-06	4.05e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PLAT—polycystic ovary syndrome	7.2e-06	4.01e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GHRL—polycystic ovary syndrome	7.2e-06	4.01e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IGF1—polycystic ovary syndrome	7.2e-06	4.01e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IGF1—polycystic ovary syndrome	7.2e-06	4.01e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.19e-06	4.01e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT2—polycystic ovary syndrome	7.19e-06	4.01e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT2—polycystic ovary syndrome	7.19e-06	4.01e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	7.19e-06	4e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.12e-06	3.97e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	7.11e-06	3.96e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.08e-06	3.94e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	7.07e-06	3.94e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	6.96e-06	3.88e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	6.94e-06	3.87e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	6.93e-06	3.86e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	6.93e-06	3.86e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—LHB—polycystic ovary syndrome	6.89e-06	3.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ATF1—polycystic ovary syndrome	6.87e-06	3.83e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CRP—polycystic ovary syndrome	6.85e-06	3.81e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IRS2—polycystic ovary syndrome	6.85e-06	3.81e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.83e-06	3.81e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.83e-06	3.81e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	6.78e-06	3.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	6.78e-06	3.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	6.74e-06	3.75e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.71e-06	3.74e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TCF7L2—polycystic ovary syndrome	6.7e-06	3.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—TH—polycystic ovary syndrome	6.66e-06	3.71e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	6.66e-06	3.71e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	6.62e-06	3.69e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.62e-06	3.69e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	6.57e-06	3.66e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.57e-06	3.66e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	6.56e-06	3.65e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	6.53e-06	3.64e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.53e-06	3.64e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	6.52e-06	3.63e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—IL6—polycystic ovary syndrome	6.49e-06	3.61e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	6.49e-06	3.61e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	6.48e-06	3.61e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.36e-06	3.54e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NGFR—polycystic ovary syndrome	6.34e-06	3.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PRL—polycystic ovary syndrome	6.28e-06	3.5e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	6.25e-06	3.48e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	6.21e-06	3.46e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	6.19e-06	3.45e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	6.19e-06	3.45e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	6.14e-06	3.42e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.12e-06	3.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	6.11e-06	3.4e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	6.09e-06	3.39e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	6.05e-06	3.37e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—LHB—polycystic ovary syndrome	6.04e-06	3.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	6.04e-06	3.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	6e-06	3.34e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IRS1—polycystic ovary syndrome	5.98e-06	3.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.96e-06	3.32e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	5.9e-06	3.29e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PRL—polycystic ovary syndrome	5.86e-06	3.26e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	5.86e-06	3.26e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	5.85e-06	3.26e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—RRM2—polycystic ovary syndrome	5.82e-06	3.24e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.8e-06	3.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	5.72e-06	3.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	5.64e-06	3.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	5.64e-06	3.14e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL6—polycystic ovary syndrome	5.62e-06	3.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—YAP1—polycystic ovary syndrome	5.61e-06	3.12e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IGF1—polycystic ovary syndrome	5.58e-06	3.11e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT2—polycystic ovary syndrome	5.58e-06	3.11e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT2—polycystic ovary syndrome	5.53e-06	3.08e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GNAS—polycystic ovary syndrome	5.53e-06	3.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	5.51e-06	3.07e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL6—polycystic ovary syndrome	5.5e-06	3.07e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL6—polycystic ovary syndrome	5.5e-06	3.07e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	5.44e-06	3.03e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	5.42e-06	3.02e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	5.39e-06	3e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NAMPT—polycystic ovary syndrome	5.39e-06	3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.38e-06	3e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.35e-06	2.98e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	5.35e-06	2.98e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	5.34e-06	2.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	5.32e-06	2.96e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.31e-06	2.96e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	5.3e-06	2.95e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—TH—polycystic ovary syndrome	5.29e-06	2.95e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.28e-06	2.94e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.26e-06	2.93e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	5.26e-06	2.93e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.26e-06	2.93e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	5.22e-06	2.91e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.2e-06	2.89e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	5.18e-06	2.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRG1—polycystic ovary syndrome	5.17e-06	2.88e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	5.14e-06	2.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	5.1e-06	2.84e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	5.05e-06	2.81e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	5.03e-06	2.8e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL6—polycystic ovary syndrome	5.03e-06	2.8e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	5.02e-06	2.8e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	4.97e-06	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	4.94e-06	2.75e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	4.91e-06	2.74e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	4.91e-06	2.74e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	4.91e-06	2.74e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NCOR1—polycystic ovary syndrome	4.91e-06	2.74e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	4.84e-06	2.69e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	4.83e-06	2.69e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—BCL2—polycystic ovary syndrome	4.83e-06	2.69e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRG1—polycystic ovary syndrome	4.82e-06	2.68e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.81e-06	2.68e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	4.77e-06	2.66e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	4.76e-06	2.65e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.74e-06	2.64e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	4.72e-06	2.63e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.7e-06	2.62e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.7e-06	2.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	4.66e-06	2.6e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	4.59e-06	2.56e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	4.58e-06	2.55e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—polycystic ovary syndrome	4.54e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	4.51e-06	2.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	4.44e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IRS2—polycystic ovary syndrome	4.43e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	4.41e-06	2.46e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	4.4e-06	2.45e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.38e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	4.35e-06	2.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTHFR—polycystic ovary syndrome	4.34e-06	2.42e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	4.33e-06	2.41e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—LEP—polycystic ovary syndrome	4.33e-06	2.41e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.32e-06	2.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	4.32e-06	2.4e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TH—polycystic ovary syndrome	4.3e-06	2.4e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—polycystic ovary syndrome	4.29e-06	2.39e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TH—polycystic ovary syndrome	4.28e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	4.19e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	4.16e-06	2.32e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IRS2—polycystic ovary syndrome	4.13e-06	2.3e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	4.11e-06	2.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	4.11e-06	2.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	4.05e-06	2.25e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	3.94e-06	2.19e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	3.91e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	3.9e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IRS1—polycystic ovary syndrome	3.86e-06	2.15e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TH—polycystic ovary syndrome	3.84e-06	2.14e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TH—polycystic ovary syndrome	3.75e-06	2.09e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	3.74e-06	2.08e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—POMC—polycystic ovary syndrome	3.72e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	3.71e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—INS—polycystic ovary syndrome	3.7e-06	2.06e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—POMC—polycystic ovary syndrome	3.66e-06	2.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	3.65e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	3.64e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—INS—polycystic ovary syndrome	3.64e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—polycystic ovary syndrome	3.64e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	3.63e-06	2.02e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IRS1—polycystic ovary syndrome	3.6e-06	2.01e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—polycystic ovary syndrome	3.59e-06	2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF1—polycystic ovary syndrome	3.58e-06	1.99e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT2—polycystic ovary syndrome	3.58e-06	1.99e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	3.51e-06	1.96e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	3.51e-06	1.96e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TH—polycystic ovary syndrome	3.5e-06	1.95e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GNAS—polycystic ovary syndrome	3.49e-06	1.95e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—INS—polycystic ovary syndrome	3.45e-06	1.92e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	3.43e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	3.41e-06	1.9e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.4e-06	1.89e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	3.35e-06	1.86e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT2—polycystic ovary syndrome	3.34e-06	1.86e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NCOR1—polycystic ovary syndrome	3.33e-06	1.85e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—polycystic ovary syndrome	3.25e-06	1.81e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—polycystic ovary syndrome	3.25e-06	1.81e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.2e-06	1.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	3.17e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	3.17e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	3.15e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	3.14e-06	1.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	3.06e-06	1.7e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	2.99e-06	1.66e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	2.96e-06	1.65e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	2.95e-06	1.64e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MTHFR—polycystic ovary syndrome	2.94e-06	1.64e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	2.92e-06	1.62e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—POMC—polycystic ovary syndrome	2.91e-06	1.62e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—INS—polycystic ovary syndrome	2.89e-06	1.61e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	2.86e-06	1.59e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	2.83e-06	1.58e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	2.76e-06	1.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.72e-06	1.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	2.64e-06	1.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.58e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	2.58e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—polycystic ovary syndrome	2.5e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.41e-06	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	2.4e-06	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PPARG—polycystic ovary syndrome	2.38e-06	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	2.37e-06	1.32e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—INS—polycystic ovary syndrome	2.35e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—POMC—polycystic ovary syndrome	2.35e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—INS—polycystic ovary syndrome	2.34e-06	1.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.34e-06	1.3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.14e-06	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.11e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.1e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	2.09e-06	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—POMC—polycystic ovary syndrome	2.06e-06	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—INS—polycystic ovary syndrome	2.05e-06	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.95e-06	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.92e-06	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.91e-06	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—polycystic ovary syndrome	1.62e-06	9.01e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—polycystic ovary syndrome	1.51e-06	8.4e-06	CbGpPWpGaD
